NSE filing, NSE: DBOL. Summary written from the filing by ALFA Finder's alert engine.
Dhampur Bio Organics Ltd: key numbers
- Share price
- ₹123.47
- Market cap
- ₹819.7 Cr
- Revenue (annual)
- ₹2,109 Cr
- Net profit (annual)
- ₹25.18 Cr
- P/E (TTM)
- 9.8×Sector 26.2×
- Promoter holding
- 51.00%+0.22% QoQ
- FII holding
- 0.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dhampur Bio Organics Ltd
All →Dhampur Bio Organics Management Change
Dhampur Bio Organics Limited announced the cessation of Mr. Surendra Rai Kapur as Cost Auditor due to his demise, effective October 19, 2026.
Dhampur Bio Organics Partnership
Dhampur Bio Organics entered a technology licensing agreement with Planetary SA to produce Mycoprotein, with future plans for a joint venture and offtake agreement.
- Execution
- 10 years
Dhampur Bio Organics Capacity Expansion
Dhampur Bio Organics Ltd. executed a Technology Licensing Agreement with Planetary SA to produce Mycoprotein in India, introducing a new business segment and revenue stream.
Dhampur Bio Organics Other Announcement
The company submitted the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Dhampur Bio Organics Management Change
Dhampur Bio Organics has promoted Mr. Pankaj Agarwal and Mr. Vinamra Agarwal to Vice President roles. These leadership changes are effective from October 01, 2026.
Dhampur Bio Organics Promoter Buying: ₹1.04 Cr
Promoter group entity Sonitron Limited acquired 85,000 shares of Dhampur Bio Organics Ltd via open market purchases for an aggregate value of ₹1.04 Crore.
- Value
- ₹1.04 Cr
- Promoter stake change
- +0.13%
Other other announcement announcements
All →Titan Company Other Announcement
Titan's employee stock option trust transferred 19,385 shares worth Rs.8.40 Crore to eligible employees after PSU exercise. The off-market transfer was disclosed under PIT Reg 7(2).
- Value
- ₹8.40 Cr
Hindustan Petroleum Corporation Other Announcement
HPCL filed its quarterly share capital reconciliation audit certificate for the quarter ended September 30, 2026. It confirms 212.85 crore issued shares, matching listed and depository records.
KRN Heat Exchanger and Refrigeration Other Announcement
KRN Heat Exchanger filed its Reg 32 statement confirming no deviation in QIP fund use, with INR 349.99 Crore raised on 1 June 2026. The utilisation table reports no variation across the three objects.
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals reported no deviation in utilising the Rs 95 Crore raised via a preferential warrant issue for the quarter ended September 30, 2026. Audit Committee reviewed the statement and the Board took it on record.
- Value
- ₹95.00 Cr
NIIT Learning Systems Other Announcement
NIIT Learning Systems board recommended appointing Price Waterhouse Chartered Accountants LLP as statutory auditor for five years from the 25th AGM. The incumbent S. R. Batliboi firm completes its second term.
- Execution
- Five consecutive years, from the 25th AGM (2027) until the 30th AGM (2032)
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months